Overview

A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Metformin

Status:
Completed
Trial end date:
2016-06-26
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the pharmacokinetic interactions between ASP015K and metformin in healthy non-elderly male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Metformin
Peficitinib